AI assistant
Bliss GVS Pharma Limited — Share Issue/Capital Change 2021
Sep 6, 2021
61284_rns_2021-09-06_5269a384-41c9-4ac7-89b1-0472092def23.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
BLISS GVS PHARMA LTD.

September 06, 2021
| To | To |
|---|---|
| The Manager, Listing Department | The General Manager, Listing Department |
| National Stock Exchange of India Ltd. | BSE Limited |
| Plot no. C/1 G Block, | Phiroze Jeejeebhoy Towers, |
| Bandra-Kurla Complex, Bandra (East), |
Dalal Street, |
| Mumbai- 400 0.51 | Mumbai- 400 001 |
| Symbol: BLISSGVS | Scrip Code: 506197 |
Dear Sir/Madam,
Subject: Allotment of Shares under Bliss GVS Pharma Limited -Employee Stock Options Plan 2019
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on September 06, 2021 has approved the allotment of 1,51,750 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019')
Consequent to the aforesaid allotment, Issued, subscribed & paid-up share capital of the Company has increased as under:
| From | To |
|---|---|
| of Re. 1/- equity shares 10,33,57,172 each |
10,35,08,922 equity shares of Re. 1/- each |
| aggregating Rs. 10,33,57,172/- | aggregating Rs. 10,35,08,922/- |
In terms of Regulation lO(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 the details of shares allotted as above are given in' Annexure-I':
Thanking you. Yours Faithfully,
Factory: Encl: As above Regd. Office : 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL. : ( +91) (22) 42160000/ 28505387 • FAX. : ( +91) (22) 28563930, Email: [email protected] •Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Na gar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. • Email : [email protected]

'Annexure - I'
Regulation lO(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
| address and Name of Company |
Bliss GVS Pharma Limited Add: Hyde Park, Sakivihar Road, 102, |
|---|---|
| Registered Office | Andheri (East), Mumbai - 400072 |
| Name of the Stock Exchanges on which | BSE Limited |
| the Company's shares are listed | The National Stock Exchange of India |
| Limited | |
| Filing date of the statement referred in | 14/02/2020 |
| regulation lO(b) of the SEBI (Share Based | |
| Regulations, 2014 Benefits) Employee |
|
| (Share Based with read the SEBI |
|
| Equity) Benefits and Sweat Employee |
|
| the recognized 2021 with Regulations, |
|
| Stock Exchange Filing Number, if any |
Application No: |
| BSE -106063 | |
| NSE- 23188 | |
| In-Principle Approval Letter: | |
| DCS/FL/DS/ESOP-IP / 542/20 19- BSE: |
|
| 20 dated February 27, 2020 | |
| NSE: NSE/LIST/23188 dated March 04, |
|
| 2020 | |
| Title of the Scheme pursuant to which |
Limited-Employee Pharma Bliss GVS |
| shares are issued, if any | Stock Option Plan 2019 |
| Kind of security to be listed | Equity Shares |
| Par value of the shares | Re. 1/- Per Share |
| Date of issue of shares | September 06, 2021 |
| Number of shares issued | 1,51,750 |
| Share Certificate No., if applicable | Not Applicable |
| share, if number the Distinctive of |
(both to 10,35,08,922 10,33,57,173 |
| applicable | inclusive) |
| ISIN Number of the shares if issued in | INE416D01022 |
| Demat |


| Exercise price per share | Rs. 43 / - per share |
|---|---|
| per share Premium |
Rs. 42/ - per share |
| Total Issued shares after this issue | 10,35,08,922 |
| Total Issued share capital after this issue | Rs. 10,35,08,922/ - |
| Details of any lock-in on the shares as per | of 6 (six) months Lock in for a period allotment date of of Equity the from Shares. |
| Date of expiry of lock-in | March 05, 2022 |
| shares identical in all respects Whether to if not, existing shares when will they identical? become |
All equity shares of the Company allotted pursuant to exercise of stock options shall equity with the existing rank pari-passu shares of the Company |
| of listing fees, if payable Details |
Not applicable |
Relevant disclosures as per SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015
| Options Vested | 690250 Equity Shares |
|---|---|
| within which option be may Time |
months Within a period of 6 (Six) from |
| exercised | the date of vesting of such options. |
| Options exercised | Equity Shares 1,51,750 |
| Money realized bv exercise of options |
Rs. 65,25,250/- |
| total number of shares arising as The |
1,51,750 Equity Shares |
| result of exercise of option |
|
| Options lapsed | - |
| Diluted earnil;-gs per share pursuant to | Rs. 6.52/ -per share |
| shares exercise of equity on of issue |
|
| options | |
| Whether the scheme is in terms of SEBI | Yes |
| Benefits Employee and (Share Based |
|
| Sweat Equity) Regulations, 2021 |
